Preliminary efficacy and safety of acetyl-CoA carboxylase inhibitor GS-0976 in patients with compensated cirrhosis due to NASH
S. Harrison, Mazen Noureddin, Robert Herring, P. Ruane, B. Mccolgan, Barbara D. Kirby, Christian J. Nelson, Raul Aguilar Schall, C. Jia, Madhu Subramanian, R. Myers, Mark R. Middleton, Claude B. Sirlin, Mark Fitch, K. Li, Marc Hellerstein, Eric Lawitz (2018). Preliminary efficacy and safety of acetyl-CoA carboxylase inhibitor GS-0976 in patients with compensated cirrhosis due to NASH. , 68, DOI: https://doi.org/10.1016/s0168-8278(18)31425-9.
